RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shandong Weigao Group Medical Polymer Co Stock

Shandong Weigao Group Medical Polymer Co P/E 2024

Shandong Weigao Group Medical Polymer Co P/E

8.65

Ticker

1066.HK

ISIN

CNE100000171

WKN

A0M4WA

As of Sep 13, 2024, Shandong Weigao Group Medical Polymer Co's P/E ratio was 8.65, a -64.29% change from the 24.22 P/E ratio recorded in the previous year.

The Shandong Weigao Group Medical Polymer Co P/E history

Shandong Weigao Group Medical Polymer Co Aktienanalyse

What does Shandong Weigao Group Medical Polymer Co do?

Shandong Weigao Group Medical Polymer Co Ltd is a globally operating company with headquarters in Weihai, China. It was founded in 1988 and has been listed on the Hong Kong Stock Exchange since 2004. The company specializes in the production of medical polymer products and offers a wide range of products for various applications. Its business model is that of an integrated platform for research, development, manufacturing, and marketing of medical devices. Their customers include hospitals, medical practices, and distributors worldwide. The company's portfolio includes products in the areas of infusion, blood transfusion, dialysis, surgery, anesthesia, first aid, and diagnostics. Both disposable and reusable products are available. With its offering, the company aims to contribute to improving the quality of healthcare and providing better outcomes for patients. Shandong Weigao Group Medical Polymer Co Ltd is divided into three divisions: Medical Devices, Medical Consumables, and Biology. The Medical Devices division manufactures devices for use in anesthesia, surgery, resuscitation, and diagnostics. The Medical Consumables division includes products such as syringes, catheters, infusion and transfusion devices, disposable gloves, and wound dressings. The Biology division specializes in the development, manufacturing, and marketing of biopharmaceutical products, such as insulin. The company's history is characterized by rapid expansion and continuous growth. The focus on R&D has played an important role in this. Through the use of advanced technologies, the company has acquired a multitude of patents in both China and other countries. The company places a strong emphasis on quality assurance and has implemented a comprehensive quality control system. In addition, it aims to minimize its environmental impact and therefore operates according to the latest environmental standards. In recent years, the company has established an international presence and opened subsidiaries in Europe and the USA. This demonstrates the company's desire to grow internationally and offer its products in more and more countries. In summary, Shandong Weigao Group Medical Polymer Co Ltd is an innovative company specializing in the production of medical polymer products and biopharmaceutical products. It offers a wide range of products and is committed to a comprehensive quality control system and sustainability. With its international presence, the company aims to continue growing and offer its products worldwide. Shandong Weigao Group Medical Polymer Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Shandong Weigao Group Medical Polymer Co's P/E Ratio

The Price to Earnings (P/E) Ratio of Shandong Weigao Group Medical Polymer Co is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Shandong Weigao Group Medical Polymer Co's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Shandong Weigao Group Medical Polymer Co is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Shandong Weigao Group Medical Polymer Co’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Shandong Weigao Group Medical Polymer Co stock

What is the price-to-earnings ratio of Shandong Weigao Group Medical Polymer Co?

The price-earnings ratio of Shandong Weigao Group Medical Polymer Co is currently 8.65.

How has the price-earnings ratio of Shandong Weigao Group Medical Polymer Co changed compared to last year?

The price-to-earnings ratio of Shandong Weigao Group Medical Polymer Co has increased by -64.29% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Shandong Weigao Group Medical Polymer Co high compared to other companies?

Yes, the price-to-earnings ratio of Shandong Weigao Group Medical Polymer Co is high compared to other companies.

How does an increase in the price-earnings ratio of Shandong Weigao Group Medical Polymer Co affect the company?

An increase in the price-earnings ratio of Shandong Weigao Group Medical Polymer Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Shandong Weigao Group Medical Polymer Co affect the company?

A decrease in the price-earnings ratio of Shandong Weigao Group Medical Polymer Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Shandong Weigao Group Medical Polymer Co?

Some factors that influence the price-earnings ratio of Shandong Weigao Group Medical Polymer Co are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Shandong Weigao Group Medical Polymer Co pay?

Over the past 12 months, Shandong Weigao Group Medical Polymer Co paid a dividend of 0.25 CNY . This corresponds to a dividend yield of about 6.24 %. For the coming 12 months, Shandong Weigao Group Medical Polymer Co is expected to pay a dividend of 0.27 CNY.

What is the dividend yield of Shandong Weigao Group Medical Polymer Co?

The current dividend yield of Shandong Weigao Group Medical Polymer Co is 6.24 %.

When does Shandong Weigao Group Medical Polymer Co pay dividends?

Shandong Weigao Group Medical Polymer Co pays a quarterly dividend. This is distributed in the months of November, July, July, November.

How secure is the dividend of Shandong Weigao Group Medical Polymer Co?

Shandong Weigao Group Medical Polymer Co paid dividends every year for the past 23 years.

What is the dividend of Shandong Weigao Group Medical Polymer Co?

For the upcoming 12 months, dividends amounting to 0.27 CNY are expected. This corresponds to a dividend yield of 6.79 %.

In which sector is Shandong Weigao Group Medical Polymer Co located?

Shandong Weigao Group Medical Polymer Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shandong Weigao Group Medical Polymer Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shandong Weigao Group Medical Polymer Co from 11/22/2024 amounting to 0.092 CNY, you needed to have the stock in your portfolio before the ex-date on 10/18/2024.

When did Shandong Weigao Group Medical Polymer Co pay the last dividend?

The last dividend was paid out on 11/22/2024.

What was the dividend of Shandong Weigao Group Medical Polymer Co in the year 2023?

In the year 2023, Shandong Weigao Group Medical Polymer Co distributed 0.172 CNY as dividends.

In which currency does Shandong Weigao Group Medical Polymer Co pay out the dividend?

The dividends of Shandong Weigao Group Medical Polymer Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Shandong Weigao Group Medical Polymer Co

Our stock analysis for Shandong Weigao Group Medical Polymer Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shandong Weigao Group Medical Polymer Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.